Profitability
Weight: 25%
B-
62
- 5yr Avg ROIC 18.7%
- Operating Margin Trend -7.76 pp/yr
REGN
Regeneron Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
A
90
- 5yr Avg ROE 21.4%
- 5yr Share-Count CAGR -1.2%
Growth Quality
Weight: 25%
B
75
- 5yr Revenue CAGR 11.0%
- 5yr EPS CAGR 6.3%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 20%
A+
95
- 5yr FCF Margin 31.8%
- 5yr FCF/NI Conversion 0.90x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -1.01x
- Interest Coverage (EBIT/Int) 120.42x
- Altman Z-Score 7.79
Stability
Weight: 5%
C-
44
- EPS Volatility (σ/μ) 0.67
- Negative-Revenue Years (5) 1/5
- Piotroski F-Score 5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.4 of 4 gurus held; 3 added; 1 trimmed.
- Holders
- 4
- Avg Δ position
- +30.7%
- New buys
- 0
- Full exits
- 0